November 13, 2019

Discovering Biotech Startups: 712 North

In the latest edition of Discovering Biotech Startups, we're looking at San Francisco's 712 North!

October 30, 2019

Discovering Biotech Startups: A map for Selling to Quartz Therapeutics

Next up in the Sponsor Atlas: Discovering Biotech Startups series is Palo Alto's Quartz Therapeutics!

October 25, 2019

Discovering Biotech Startups: A map for Selling to Abtelum Biomedical

In this edition of Sponsor Atlas: Discovering Biotech Startups, we're examining Westwood, MA's Abtelum Biomedical

October 21, 2019

Sales Intelligence Products: Things to Consider for Your Team

A followup to our previous sales tech stack story, we're taking a deeper look at sales intelligence products, and things your team should consider when investing in your tech stack.

October 21, 2019

Discovering Biotech Startups: A map for Selling to KayoThera

In the latest edition of Sponsor Atlas: Discovering Biotech Startups, we're looking at Princeton, New Jersey's stealth biotech, KayoThera!

October 15, 2019

Discovering Biotech Startups: A map for Selling to Scopus Biopharma

In this edition of Discovering Biotech Startups, we're looking at New York's Scopus Biopharma!

October 9, 2019

Discovering Biotech Startups: A map for Selling to MedaRed

In the newest edition of Sponsor Atlas: Discovering Biotech Startups, we're looking at San Francisco's MedaRed!

September 16, 2019

Discovering Biotech Startups: A map for selling to Praxis Precision Medicines

In the newest edition of Discovering Biotech Startups, we're taking a look at Cambridge's Praxis Precision Medicines. Check it out!

September 9, 2019

Discovering Biotech Startups: A map for Selling to Virogenics

The latest edition of Discovering Biotech Startups is looking at San Diego's Virogenics. Check it out!

September 3, 2019

California Biotech Funding in August 2019

Funding activity in California for August 2019

September 3, 2019

Discovering Biotech Startups: A map for Selling to Vitalex Biosciences

In this edition of Discovering Biotech Startups, we're looking at the emerging California stealth biotech, Vitalex Biosciences

August 26, 2019

Discovering Biotech Startups: A map for Selling to Deciduous Therapeutics

The newest edition of Sponsor Atlas: Discovering Biotech Startups takes a look at San Francisco's stealth biotech, Deciduous Therapeutics

August 13, 2019

Discovering Biotech Startups: A map for Selling to Ignite Biosciences

The newest edition of Sponsor Atlas: Discovering Biotech Startups takes a look at Menlo Park's stealth biotech, Ignite Biosciences

August 8, 2019

Massachusetts Biotech Funding in July 2019

Funding activity in Massachusetts for July 2019

July 25, 2019

California Biotech Funding in July 2019

Funding activity in California for July 2019

July 19, 2019

Discovering Biotech Startups: A map for Selling to BlueSphere Bio

The first edition of Sponsor Atlas: Discovering Biotech Startups takes a look at Pittsburgh's stealth biotech, BlueSphere Bio

July 8, 2019

California Biotech Funding in June 2019

Funding activity in California for June 2019

July 4, 2019

Massachusetts Biotech Funding in June 2019

Funding activity in Masschusetts for June 2019

May 30, 2019

M&A in May 2019

A recap of some mergers and acquisitions across pharma/biotech in May 2019

March 15, 2019

Sponsor Pipeline Insights: The Most Active Drug Companies in Japan

Which Japanese drug sponsors were the most active in the past year? Let's find out!

February 28, 2019

February 2019 Buys

Welcome back to Flagged Events: M&A, where we recap some of the latest mergers & acquisition activities across pharma for the month.

February 5, 2019

Mapping Merck: A map for Selling to Merck & Co.

Merck & Co. is an American pharmaceutical company, ranked 4th internationally in the world in terms of 2017 prescription sales [1]. It is important to note that Merck & Co. is a wholly separate and independent company from the German company Merck KGaA, despite the fact that the two share a common origin and brand name.

January 29, 2019

Splurges & Sprees to kick off 2019

A look at some of the M&A activity across pharma to kick off 2019!

January 14, 2019

Anything but Generic: A map for Selling to Teva Pharmaceuticals

The latest edition of the Sponsor Atlas series takes a look at Israel's generics giant, Teva Pharmaceuticals.

November 14, 2018

Navigating Novo: A Map for Selling to Novo Nordisk

Born from the 1989 merger between Denmark’s top two insulin producers, Novo Nordisk markets products to over 165 countries. Learn how and where they make decisions about outsourcing activities in clinical research, contract manufacturing, logistics, and more.

October 15, 2018

From A to Z: A map for Selling to AstraZeneca

The latest edition of our Sponsor Atlas: Selling to the Pharma Giants series, where we are taking a look at AstraZeneca.

September 7, 2018

Sponsor Pipeline Insights: The Most Active Drug Companies in France

Let's take a look at the most active clinical study registrants in France!

August 20, 2018

Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're visiting New York City's biopharma behemoth, Bristol-Myers Squibb (BMS). Their three-part name was born in 1989 merger between the Squibb Corporation and the Bristol-Myers Corporation, two NYC-based pharmaceutical companies founded in 1858 and 1887, respectively.

July 23, 2018

Started From Aspirin™, Now They’re Here: A map for Selling to Bayer

Part 2 of our Sponsor Atlas: Selling to the Pharma Giants blog series. It's off to Germany for the latest stop on our expedition, to visit Bayer and understand how they make their outsourcing decisions and how best to find opportunities.

July 13, 2018

Sponsor Pipeline Insights: The Most Active Drug Companies in the American Northeast

For this edition of our Sponsor Pipeline Insights, we're taking a trip up to the American Northeast to check out the top 10 most active clinical study registrants.

June 26, 2018

Sponsor Pipeline Insights: The Most Active Drug Companies in New York

We live in a time where lists make up much of the content that appears in our timelines each day. So, why not ride the wave? Everybody loves a good list, after all! Here's a list of the top 10 most active drug sponsor companies in New York State.

May 30, 2018

Allergan eats Kythera: Karan Therapeutics is born

(10/05/2015) There isn’t much out there about California’s newest biotech company, but here are a few clues to set you on your way.

May 30, 2018

Building your Sales Software Stack: Don't get Lost in the Noise

Choosing the right software tools for your team is a difficult task, especially when operating on a limited budget. Making smart decisions about what your team will actually use can lead to higher effectiveness.

May 30, 2018

Prospect Viscosity

(02/07/2014) We often get asked the question “how much prospecting should my Business Development team be doing?” The answer to this comes down to deciding what you want your sales pipeline to look like and how comfortable you are with risking a drought in deal flow.

May 30, 2018

CRIO Deals – Impact on Your Biotech Business Development Process

(04/08/2015) Contract Research and Investment Organizations (CRIOs) are an emerging entity in the biotech drug development space that can have an unforeseen impact on your team’s sales productivity. This article discusses critical considerations for teams that encounter a CRIO deal—ten real examples are included as a starting point to better understand this trend.

May 16, 2018

Marketing vs. Sales: Their Major Difference and How They Work Together

Do your sales & marketing teams stand united or divided?

May 16, 2018

5 Sales Prospecting Tactics that Work for Biotech and Pharma Professionals

Prospecting is typically a dreaded part of the sales process. It goes something like this: Identify target companies. Search LinkedIn to see if you know anyone at the company. Place cold calls or send out generic emails and hope that you get a response. Rinse and repeat.

May 16, 2018

Can I still cold email European pharma companies under GDPR?

A guide to GDPR for service provider companies selling to pharmaceutical & biotech companies in Europe. With strict new regulations being implemented, how can you reach your potential customers?

May 15, 2018

Coherus Biosciences' Outsourcing Strategy

(09/28/2014) With Coherus Biosciences’ $86 Million IPO announced last week, we wanted to take a closer look at the companies that stand to benefit the most from the upcoming injection of capital.

May 15, 2018

Decisions, Decisions: A map for Selling to Novartis

Multinational giants like Novartis can be a tough sell for service provider companies when they don't know where to target. Understanding where decisions about different kinds of outsourced activities take place can help you close more new business. Join us for part one of our new series Sponsor Atlas: Selling to the Pharma Giants!

May 15, 2018

What has your CRM done for you lately?

Guest post by Ty Quinn. The Contract Research Organization (CRO) sector is complex. Business Development professionals are required to maintain accurate and organized records of any/all accounts, contacts, interactions and opportunities and to be able to call on them at a moment’s notice.